PET CT better than contrast-enhanced CT as survival predictor in metastatic breast cancer patients
Researchers have found in a new research that PET CT better than contrast-enhanced CT as survival predictor in metastatic breast cancer patients. 2-[18F]FDG-PET/CT, when used to monitor metastatic breast cancer, appears to be a stronger predictor of progression-free and disease-specific survival than conventional contrast-enhanced CT (CE-CT), says an article published in Scientific Reports. Metastatic breast […] More